Thank you, Zoe. I will answer your questions. The first question, basically, in Q2, because of the slow recovery of the macro economy, we continue to adopt a prudent strategy. Basically, the total loan origination declined by 12%, and the loan balance dropped by about 5% quarter-over-quarter. However, because of our focus on improving the operational efficiency and strengthened core capabilities, the revenue take rate increased significantly from 2.54% in Q1 to 2.91%. Basically, it's a substantial rise of 37 basis points quarter-over-quarter and about 54 basis point if you compare year-over-year. This is really because of many reasons. Basically, the first one is, as Arvin mentioned, tightened risk standards boasted a continuous improvement in the quality of new loans this quarter. And also secondly, a significant reduction in the funding cost. And thirdly, some further optimizations of early repayment ratio, a risk-based differentiated pricing and more value-added services. Looking ahead into the third quarter, we will continue to uphold the prudent operational strategy, and we expect the revenue take rate to maintain a slight uptick momentum in the near future. As for the second question related to funding cost, basically, this quarter, the funding cost reached a new record low, stood at about 5.26%. It decreased by 58 basis point quarter-over-quarter. It is a really big reduction. Really, this is driven by many factors. The first is the overall liquidity in the market. It remains relatively ample, and our quality assets are in high demand amongst the trending -- funding partners. So, this reflects our continuously improving asset quality has gained more recognition from funding partners. Really, this helps us to drive down the funding cost. Secondly, as for our profit-sharing model, the revenue split ratio increased by 1 percentage point quarter-over-quarter and 4 percentage point year-over-year. Again, this demonstrates the competitiveness of our assets and our strong bargaining power, if you will. And the third point is the continuous ABS issuers. As Jay and I both talked about in our script, we issued two tranches of ABS with the senior tranche as low as 2.8%. This really significantly pull down our funding cost. And we plan to regularly issue ABS to further balance and diversify our funding channels. And in terms of funding structure, in Q2, we added two more funding partners to our existing 160 partners network. So, with the proportion of funds from national funding partners maintaining at about 70% or so. So, looking ahead, with the acceleration pace of the ABS assurance and continuous improvement in asset quality, if the overall liquidity remains sufficient in the financial market, we believe there is still considerable room for further reduction in funding cost in the near future. So hopefully, this answers your questions.